New Cook Coronary Stent Receives FDA Clearance

May 20, 1997

Bloomington, Ind. - Cook Incorporated, manufacturer of the first coronary stent cleared for clinical use in the United States, has received U.S. Food and Drug Administration clearance to market its new low-profile, highly trackable GR II® Coronary Stent in the U.S.

FDA's clearance notification on May 12, 1997 makes the Cook GR II® the first new coronary stent cleared for clinical use in the United States since 1994. Cook's earlier coronary stent, the Gianturco-Roubin Flex StentR, has been commercially available in the U.S. since June 1993, with more than 100,000 U.S. implants.

Cook's GR II® Coronary Stent, available in 20 mm and 40 mm lengths, is indicated for treatment of acute or threatened vessel closure in patients with failed interventional therapy in vessels with reference diameters in the range of 2.1 mm to 4.0 mm.

The GR II® Coronary Stent allows placement in a wide variety of lesions. Its clinically significant design features include:

"Even before bringing the first coronary stent to the U.S. marketplace, Cook, through its cardiology division, was already working with cardiologists to create an improved stent design that recognized the coronary anatomy's unique requirements," explained Phyllis McCullough, president of Cook Incorporated. "The success of our new GR II® coronary stent, which is now available around the world, demonstrates Cook's unique ability to respond quickly to rapid changes in the medical industry with products developed in conjunction with physicians to enhance patient outcomes."

Founded in 1963 with headquarters in Bloomington, Ind., Cook Incorporated ( has become a leading global manufacturer and distributor of medical products and interventional devices for radiology, cardiology, oncology, neurology, general surgery, critical care and other medical disciplines.

- end text -

Cook, Inc.

Related Stent Articles from Brightsurf:

In-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass
In a new publication from Cardiovascular Innovations and Applications; DOI, Nathan Burke, Tawanna Charlton, Hussam Hawamdeh, and Ki Park from the University of Florida College of Medicine, Gainesville, Florida, USA consider a case study of in-stent thrombosis after antiplatelet therapy conversion while awaiting coronary bypass.

Late coronary stent thrombosis in patient with COVID-19
This case report describes a patient with COVID-19 who developed late drug-eluting stent thrombosis.

Randomization of provisional vs two-stent techniques in complex bifurcation lesions
Aim: The present study aimed to assess the benefits of two-stent techniques for patients with DEFINITION criteria-defined complex coronary bifurcation lesions.

Leg pain medication may prevent re-blockage of neck arteries after a stent
Adding cilostazol, an antiplatelet medication for leg pain, to other drugs tended to prevent re-blockage of carotid artery stents within two years.

The world's smallest stent
Researchers at ETH Zurich have developed a new method for producing malleable microstructures -- for instance, vascular stents that are 40 times smaller than previously possible.

Type of stent affects immediate and long-term outcomes
A new study comparing the outcomes of different types of stents used to treat cerebral aneurysms shows that the type of stent used affects a patient's immediate and long-term health outcomes.

Stopping DAPT after one-month improved outcomes in stent patients
Patients who stopped taking aspirin one month after receiving a stent in the heart's arteries but continued taking the P2Y12 inhibitor clopidogrel fared significantly better after one year compared with those who followed the standard practice of continuing both medications, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Sugary stent eases suturing of blood vessels
A team led by the University of Nebraska-Lincoln and Harvard Medical School has concocted a sugar-heavy stent to reduce the margin of error in a delicate surgical procedure.

Non-invasive stent monitoring techniques tested
Barcelona researchers develop a probe to detect and monitor metallic stents.

Stent retriever thrombectomy effective for longer window after stroke
A new study shows promising real-world outcomes for patients receiving a stent retriever thrombectomy six hours after they experience an acute ischemic stroke (AIS).

Read More: Stent News and Stent Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to